Azenta, Inc. (NASDAQ: AZTA) is a Healthcare company (Medical - Instruments & Supplies) with a market capitalization of $2.0B. The Maz Rating grades it against the other companies in its sector.
Azenta, Inc.'s current Maz Rating and its five factor grades are for members: log in to see them.
At $45.81, Azenta, Inc. trades at 3.2x sales and 1.4x book value. Over the last twelve months it generated about $618M of revenue and a net loss of $158M. It runs a gross margin of 44.2%, an operating margin of -27.7% and a net margin of -26.9%. It shows return on equity of -10.8%, return on invested capital of -11.7% and a free cash flow yield of 1.4%. On the balance sheet: a debt-to-equity ratio of 0.04 and a current ratio of 2.68. Over the past 52 weeks the share price ranged from $15.93 to $50.06, with a beta of 1.47.
Azenta, Inc. does not currently pay a dividend.
12 Wall Street analyst ratings cover the stock: 7 Buy and 5 Hold, for a Buy consensus. This is the sell side's view, separate from the Maz Rating.
Figures are trailing twelve months unless stated. The Maz Rating and Maz Dividend Score rank a company against its own sector; they are not price targets or recommendations.